Alan J. Malus

Filings by Alan J. Malus span 2 companies, the busiest being Thermo Fisher Scientific Inc. and Azenta, Inc. In total, 10 filings cover trades dated from 1 February 2016 to 30 May 2025.

In open-market terms, that means 1 purchase worth €281k on one side and 3 sales on the other. The totals do not cover 3 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants and 2 option exercises. In 2025 alone, the filings show 1 purchase and no sales.

The newest entry dates from 14 November 2025: an open-market purchase of €281k, in Azenta, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.